Insider Transactions last 24 months for Kiniksa Pharmaceuticals International, plc - NSDQ: KNSA
| Transactions | |||
| All | Buy | Sell | Option Exercise |
Filer's Name |
Relationship/ Title |
Trans. Date |
Trans. Type |
Ownership Type |
Security Type |
Shares |
Price |
Trans. Value |
Total Shares Owned |
| Quart Barry D | Director | 06/06/2024 | AM | Direct | COM | 4,373 | $0.00 | $0.00 | 9,373 |
| Popovits Kimberly J | Director | 06/06/2024 | AM | Direct | COM | 4,373 | $0.00 | $0.00 | 9,373 |
| Mccain Tracey L | Director | 06/06/2024 | AM | Direct | COM | 4,373 | $0.00 | $0.00 | 9,373 |
| Malley Thomas | Director | 06/06/2024 | AM | Direct | COM | 4,373 | $0.00 | $0.00 | 9,373 |
| Levy Richard S | Director | 06/06/2024 | AM | Direct | COM | 4,373 | $0.00 | $0.00 | 12,897 |
| Cole G Bradley | Director | 06/06/2024 | AM | Direct | COM | 4,373 | $0.00 | $0.00 | 9,373 |
| Baker Bros. Advisors Lp | Director | 06/05/2024 | AA | Indirect | COM | 6,346 | $0.00 | $0.00 | 2,725,689 |
| Baker Bros. Advisors Lp | Director | 06/05/2024 | AA | Indirect | COM | 6,346 | $0.00 | $0.00 | 124,072 |
| Levy Richard S | Director | 05/03/2024 | AM | Direct | COM | 747 | $0.00 | $0.00 | 8,524 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | 04/26/2024 | DF | Direct | COM | 509 | $17.88 | $9,100.92 | 19,253 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | 04/26/2024 | AM | Direct | COM | 991 | $0.00 | $0.00 | 19,762 |
| Tessari Eben | CHIEF OPERATING OFFICER | 04/08/2024 | DF | Direct | COM | 801 | $17.90 | $14,337.90 | 126,024 |
| Tessari Eben | CHIEF OPERATING OFFICER | 04/08/2024 | AM | Direct | COM | 2,726 | $0.00 | $0.00 | 126,825 |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | 04/08/2024 | DF | Direct | COM | 1,666 | $17.90 | $29,821.40 | 21,328 |
| Megna Michael R | CHIEF ACCOUNTING OFFICER | 04/08/2024 | AM | Direct | COM | 3,932 | $0.00 | $0.00 | 22,994 |
| Moat Ross | CHIEF COMMERCIAL OFFICER | 04/08/2024 | DF | Direct | COM | 1,353 | $17.90 | $24,218.70 | 16,276 |
| Moat Ross | CHIEF COMMERCIAL OFFICER | 04/08/2024 | AM | Direct | COM | 2,477 | $0.00 | $0.00 | 17,629 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | 04/08/2024 | DF | Direct | COM | 791 | $17.90 | $14,158.90 | 18,771 |
| Ragosa Mark | CHIEF FINANCIAL OFFICER | 04/08/2024 | AM | Direct | COM | 2,694 | $0.00 | $0.00 | 19,562 |
| Paolini John F. | CHIEF MEDICAL OFFICER | 04/08/2024 | DF | Direct | COM | 733 | $17.90 | $13,120.70 | 47,803 |
| Paolini John F. | CHIEF MEDICAL OFFICER | 04/08/2024 | AM | Direct | COM | 2,497 | $0.00 | $0.00 | 48,536 |
| Patel Sanj K | CHAIRMAN & CEO | 04/08/2024 | DF | Direct | COM | 4,075 | $17.90 | $72,942.50 | 63,012 |
| Patel Sanj K | CHAIRMAN & CEO | 04/08/2024 | AM | Direct | COM | 9,992 | $0.00 | $0.00 | 67,087 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel | |||||||
© 2000 - 2026 Zacks Investment Research